TY - JOUR
T1 - DARK Classics in Chemical Neuroscience
T2 - α-Pyrrolidinovalerophenone ("Flakka")
AU - Kolesnikova, Tatiana O.
AU - Khatsko, Sergey L.
AU - Demin, Konstantin A.
AU - Shevyrin, Vadim A.
AU - Kalueff, Allan V.
N1 - Publisher Copyright:
© 2018 American Chemical Society.
PY - 2019/1/16
Y1 - 2019/1/16
N2 - Flakka (alpha-pyrrolidinovalerophenone, α-PVP) is a new psychoactive substance, chemically close to cathinone, the primary psychoactive alkaloid of khat (Catha edulis). Like other synthetic cathinones, α-PVP is a potent inhibitor of the dopamine and norepinephrine transporters. Its robust clinical effects include hallucinations, arousal, aggression/violence, and euphoria. In animal models, α-PVP evokes hyperlocomotion and aberrant/stereotypic behaviors. Here, we discuss the history, synthesis, pharmacological mechanisms, metabolism, abuse potential, and societal impact of α-PVP. Today, α-PVP is a tightly controlled substance, currently banned in the United States and other countries worldwide. However, the growing abuse and complex central nervous system (CNS) effects of α-PVP remain poorly understood, necessitating further pharmacological and pharmacogenetic studies of this drug. Its interesting pharmacological profile (co-inhibition of dopamine and norepinephrine, but not serotonin, transporters) also calls for further studies of α-PVP in animal models, to dissect serotonergic from other monoaminergic mechanisms of action of drugs of abuse. Finally, screening α-PVP and related compounds in vivo may foster discovery of new CNS drugs, including developing novel CNS drugs and identifying their molecular targets.
AB - Flakka (alpha-pyrrolidinovalerophenone, α-PVP) is a new psychoactive substance, chemically close to cathinone, the primary psychoactive alkaloid of khat (Catha edulis). Like other synthetic cathinones, α-PVP is a potent inhibitor of the dopamine and norepinephrine transporters. Its robust clinical effects include hallucinations, arousal, aggression/violence, and euphoria. In animal models, α-PVP evokes hyperlocomotion and aberrant/stereotypic behaviors. Here, we discuss the history, synthesis, pharmacological mechanisms, metabolism, abuse potential, and societal impact of α-PVP. Today, α-PVP is a tightly controlled substance, currently banned in the United States and other countries worldwide. However, the growing abuse and complex central nervous system (CNS) effects of α-PVP remain poorly understood, necessitating further pharmacological and pharmacogenetic studies of this drug. Its interesting pharmacological profile (co-inhibition of dopamine and norepinephrine, but not serotonin, transporters) also calls for further studies of α-PVP in animal models, to dissect serotonergic from other monoaminergic mechanisms of action of drugs of abuse. Finally, screening α-PVP and related compounds in vivo may foster discovery of new CNS drugs, including developing novel CNS drugs and identifying their molecular targets.
KW - anxiety behavior
KW - drugs of abuse
KW - sedation
KW - synthetic cathinone
KW - Zebrafish
KW - α-PVP
UR - http://www.scopus.com/inward/record.url?scp=85057435840&partnerID=8YFLogxK
U2 - 10.1021/acschemneuro.8b00525
DO - 10.1021/acschemneuro.8b00525
M3 - Review article
C2 - 30384587
AN - SCOPUS:85057435840
SN - 1948-7193
VL - 10
SP - 168
EP - 174
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
IS - 1
ER -